B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide
BCAP29
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BCAP29
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BCAP29 antibody (Catalog #: ARP44557_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
- Synonymes
- AW208404 Peptide, Bap29 Peptide, BAP29 Peptide, B-cell receptor associated protein 29 Peptide, B cell receptor associated protein 29 Peptide, B-cell receptor-associated protein 29 Peptide, BCAP29 Peptide, Bcap29 Peptide
- Sujet
-
BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.
Alias Symbols: BAP29, DKFZp686M2086
Protein Interaction Partner: BCAP31,PDXDC1,BCAP31
Protein Size: 337 - Poids moléculaire
- 39 kDa
- ID gène
- 55973
- NCBI Accession
- NM_001008406, NP_001008406
- UniProt
- A6NCU1
-
Vous êtes ici:
